Brief: CTI Biopharma Reports Second Quarter 2020 Financial Results
Aug 6 (Reuters) - CTI Biopharma Corp CTIC.O :
* CTI BIOPHARMA REPORTS SECOND QUARTER 2020 FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $0.19
* NO REVENUES WERE RECOGNIZED FOR THREE AND SIX MONTHS ENDED
JUNE
30, 2020
* EXPECT CURRENT CASH AND CASH EQUIVALENTS WILL ENABLE US TO
FUND
OPERATIONS INTO Q4 OF 2021
Source text for Eikon: ID:nPn9d5cyya
Further company coverage: CTIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CTI Biopharma
See all newsBrief: CTI Biopharma Cancels 2023 Annual Meeting Of Stockholders
U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
U.S. STOCKS ON THE MOVE-First Citizens BancShares, Sarepta, Celsius Holdings
U.S. STOCKS ON THE MOVE-Taboola, US banks, Copper miners